Ropinirole in the treatment of Parkinson’s disease

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.5, 1999-05, pp. : 697-710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-dopaminergic drug treatment of Parkinson’s disease

By Müller T.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 557-572

Informa Healthcare

Access to resources Recommend Favorite

Emerging Therapies in the Pharmacological Treatment of Parkinsons Disease

By Korczyn A.D. Nussbaum M.

Drugs, Vol. 62, Iss. 5, 2002-01 ,pp. : 775-786

Adis International

Access to resources Recommend Favorite

Treatment of Psychosis in Parkinsons Disease: Safety Considerations

By Fernandez H.H. Trieschmann M.E. Friedman J.H.

Drug Safety, Vol. 26, Iss. 9, 2003-01 ,pp. : 643-659

Adis International

Access to resources Recommend Favorite

Recent developments in the pharmacological treatment of Parkinson’s disease

By Tuite Paul Riss Jennifer

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1335-1352

Informa Healthcare

Access to resources Recommend Favorite

Cabergoline, Pramipexole and Ropinirole Used as Monotherapy in Early Parkinsons Disease: An Evidence-Based Comparison

By Inzelberg R. Schechtman E.

Drugs & Aging, Vol. 20, Iss. 11, 2003-01 ,pp. : 847-855

Adis International

Access to resources Recommend Favorite